The 15-minute test runs on the Diasorin Liaison Nes system and obviates the need for molecular confirmation of negative rapid immunoassay results.

Diagnostic test maker Meridian Bioscience (NASDAQ:VIVO) has received regulatory clearance of a molecular diagnostics test for group B streptococcus. The group B strep test is the second in the ...

Nexsen Biotech Pty Ltd. developed a rapid diagnostic test for Group B Streptococcus, a highly prevalent and potentially fatal bacteria that is the single largest maternal health problem faced by ...

Strep throat is a common throat infection that often causes a sore throat, fever and trouble swallowing. It tends to come on ...

A new vaccine for Group B streptococcal bacteria in pregnant women is one step closer to arriving in doctors’ offices someday. Preliminary findings from a Phase 2 study found a vaccine covering three ...

In newborns, symptoms of group B strep diseases, like fever and lethargy, typically appear within their first week of life. Adults typically have no symptoms, unless their infection is severe. Group B ...